Market Introduction
Europe molecular biology enzymes, kits & reagents market comprises Germany, France, Italy, UK, Spain, and rest of Europe. The growth of the market is attributed to the increasing cancer disease and increasing investments by the governments in the region. In addition, the rising COVID-19 population are likely to foster the growth of the molecular biology enzymes, kits & reagents market in the country. The rest of Europe consists of countries like Russia, Poland, Austria, Switzerland, Sweden, Norway, Denmark, Belgium, Netherlands, and others. The pharmaceutical sector has traditionally been a vibrant, innovation-driven, and highly successful component of industry at large. In recent years, a confluence of spectacular advances in chemistry, molecular biology, genomics, and chemical technology and the cognate fields of spectroscopy, chromatography, and crystallography have led to the discovery and development of numerous novel therapeutic agents for the treatment of a wide spectrum of diseases. A measure of innovation in the pharmaceutical sector is the number of launches of new chemical and biological entities. In the last decades there has been an increasing competition in the section of research in Europe. Increasing research & development activities and clinical trials, the growing number of clinical and research laboratories have boosted the demand for molecular biology enzymes, kits & reagents market.
Italy, Spain, the UK, Germany, France, and several other European counties such as Russia and Switzerland were highly affected. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK were among the most affected European countries, and the number of deaths was also high. The COVID-19 outbreak has been declared by the World Health Organization (WHO) as a Public Health Emergency of International Concern, according to the International Health Regulations. Increasing number of product launches in 2020 and the rising incidence of COVID-19 have positively impacted the Europe molecular biology enzymes, kits & reagents market. In 2020, European Medicines Agency (EMA) approved about 97 medicines for marketing authorization, of which 39 are novel drugs. Similarly, in October 2020, Eurofins introduced COVID-19 PCR tests with at-home self-sampling options in Europe.
Market Overview and Dynamics
The molecular biology enzymes, kits, and reagents market in Europe is expected to grow from US$ 4,125.28 million in 2021 to US$ 12,561.60 million by 2028; it is estimated to grow at a CAGR of 17.2% from 2021 to 2028. Increased adoption of molecular diagnostics procedures for detecting infectious diseases, coupled with advent of new cancer diagnostic solutions, is likely to support the molecular biology enzymes, kits, and reagents market growth during the forecast period. Molecular diagnostics tests are used for detecting disturbance between specific sequences in DNA or RNA. The irregularities such as single nucleotide polymorphism (SNP), deletions, rearrangements, and insertions lead to various diseases, including infectious diseases, cancer, viral disease, and sexually transmitted diseases (STDs). Such high prevalence of infectious diseases and increasing incidences of cancer are leading to high traction toward molecular diagnostics, as it is capable of diagnosing diseases with high specificity, further paving the way for treating patients with precision medicine. Various governments are focused on research and development in the field of precision medicine. Therefore, the rise in focus on molecular diagnostics is emerging as a key opportunity for the molecular biology enzymes, kits, and reagents market players.
Key Market Segments
Europe molecular biology enzymes, kits, and reagents market is segmented into product, application, end user, and country. Based on product, the molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. The market, by enzymes, is further segmented into polymerases, ligases, reverse transcriptases, phosphatases, proteases and proteinases, restriction endonuclease, and other. The kits & reagent segment held a larger market share in 2020. The molecular biology enzymes, kits, and reagents market, based on application, is segmented into epigenetics, sequencing, synthetic biology, polymerase chain reaction, and other. In 2020, the sequencing segment held the largest market share. In terms of end user, the molecular biology enzymes, kits, and reagents market is segmented into biotechnological and pharmaceutical companies, hospitals and diagnostic centers, and academic and research institutes. The biotechnological and pharmaceutical companies segment held the largest share of the market in 2020. Based on country, the Europe molecular biology enzymes, kits, and reagents market is segmented into France, Germany, Italy, Spain, UK, and rest of Europe. Rest of Europe held the largest market share in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the molecular biology enzymes, kits, and reagents market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Illumina, Inc.; Merck KGAA; MERIDIAN BIOSCIENCE, INC; Promega Corporation; Qiagen; Rockland Immunochemicals Inc; and THERMO FISHER SCIENTIFIC INC.
Reasons to buy report
- To understand the Europe molecular biology enzymes, kits, and reagents market landscape and identify market segments that are most likely to guarantee a strong return.
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe molecular biology enzymes, kits, and reagents market.
- Efficiently plan M&A and partnership deals in Europe molecular biology enzymes, kits, and reagents market by identifying market segments with the most promising probable sales.
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe molecular biology enzymes, kits, and reagents market.
- Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.
Europe Molecular Biology Enzymes, Kits, and Reagents Market Segmentation
Europe Molecular Biology Enzymes, Kits, and Reagents Market - By Product
- Enzymes
- Polymerases
- Ligases
- Reverse Transcriptases
- Phosphatases
- Proteases and Proteinases
- Restriction Endonuclease
- Other
- Kits and Reagents
Europe Molecular Biology Enzymes, Kits, and Reagents Market - By Application
- Epigenetics
- Sequencing
- Synthetic Biology
- Polymerase Chain Reaction
- Other
Europe Molecular Biology Enzymes, Kits, and Reagents Market - By End User
- Biotechnological and Pharmaceutical Companies
- Hospitals and Diagnostic Centres
- Academic and Research Institutes
Europe Molecular Biology Enzymes, Kits, and Reagents Market - By Country
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Europe Molecular Biology Enzymes, Kits, and Reagents Market - Company Profiles
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
Europe Molecular Biology Enzymes, Kits, and Reagents Market Strategic Insights
Europe Molecular Biology Enzymes, Kits, and Reagents Market Report Highlights
| Report Attribute | Details |
| Market size in 2021 | US$ 4,125.28 Million |
| Market Size by 2028 | US$ 12,561.60 Million |
| CAGR (2021 - 2028) | 17.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
Europe Molecular Biology Enzymes, Kits, and Reagents Market Country and Regional Insights
